2022. Design And Synthesis Of 3-Arylcoumerin Derivatives As A Selective Mao-B Inhibitor. Journal of Pharmaceutical Negative Results. (Dec. 2022), 9820–9833. DOI:https://doi.org/10.47750/pnr.2022.13.S09.1147.